Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Quantum-First Trial: FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3 -ITD)-Specific Measurable Residual Disease (MRD) Clearance Assessed through Induction (IND) and Consolidation (CONS) Is Associated with Improved Overall Survival (OS) in Newly Diagnosed (nd) FLT3 -ITD+ AML Patients (pts)

Blood (2023) 142 (Supplement 1): 832.

https://doi.org/10.1182/blood-2023-186785

Published: 2023

Journal Articles

Impact of Allogeneic Hematopoietic Cell Transplantation in First Complete Remission in Addition to FLT3 Inhibition with Quizartinib in Acute Myeloid Leukemia with FLT3 -Internal Tandem Duplication: Results from the Quantum-First Trial

Blood (2022) 140 (Supplement 1): 2130–2132.

https://doi.org/10.1182/blood-2022-169011

Published: 2022

Journal Articles

Quantum-First Trial: FLT3 -ITD-Specific MRD Clearance Is Associated with Improved Overall Survival

Blood (2022) 140 (Supplement 1): 546–548.

https://doi.org/10.1182/blood-2022-162739

Published: 2022

Journal Articles

NOVEL-1 st : A Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Hwang Wen-Li, MD, Tsung-Chih Chen, MD, Shyuann-Yuh Lin, MD, Ming-Chih Chang, MD, Pei-Ching Hsiao, MD, Li-Yuan Bai, PhD, Ching-Yuan Kuo, Yeu-Chin Chen, MD, Ta-Chih Liu, MD PhD, Jyh-Pyng Gau, MD, Po-Nan Wang, MD, Chieh-Wen Chen, Yee-Ming Lee, PhD, Fan-Chen Ku, MD, Jih-Luh Tang, MD, PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137327

Published: 2020

Journal Articles

NOVEL-1 st : Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Hwang Wen-Li, MD, Shao-Min Han, MD, Shyuann-Yuh Lin, MD, Ming-Chih Chang, MD, Li-Yuan Bai, PhD, Pei-Ching Hsiao, MD, Ching-Yuan Kuo, Yeu-Chin Chen, MD, Ta-Chih Liu, MD PhD, Po-Nan Wang, MD, Jyh-Pyng Gau, MD, Yee-Ming Lee, PhD, Fan-Chen Ku, Jih-Luh Tang, MD

Blood (2018) 132 (Supplement 1): 3019.

https://doi.org/10.1182/blood-2018-99-112342

Published: 2018

Journal Articles

Differential Impact of Conditioning Intensity on Post-Transplant Outcome of FLT3 -Mutated and FLT3 Wild Type AML in First Remission, a Report from Taiwan Bone Marrow Transplant Registry (TBMTR)

Su-Peng Yeh, MD, Ming Yao, MD, Jih-Luh Tang, MD,PhD, Jin-Hwang Liu, MD PhD, Tzeon-Jye Chiou, MD, Tran-Der Tan, Po-Nan Wang, MD, Yeu-Chin Chen, MD, Wen-Li Hwang, MD, Ciyuan-jheng Wang, MD, Tsai-Yun Chen, MD, TA-Chih LIU, MD PhD, Ming-Sun Yu, MD, Tso-Fu Wang

Blood (2017) 130 (Supplement 1): 3229.

https://doi.org/10.1182/blood.V130.Suppl_1.3229.3229

Published: 2017

Journal Articles

Clonal Evolution of Gene Mutations in AML Transformation from Patients with De Novo Myelodysplastic Syndromes Carrying Spliceosome Mutations: An Analysis of 71 Paired Samples

Ming-Chung Kuo, MD, Po-Nan Wang, MD, Po Dunn, MD, Tung-Liang Lin, MD, Jin-Hou Wu, MD, Tzung-Chih Tang, MD, Yi-Jung Wu, MS, Tung-Huei Lin, MS, Chia-Hui Chang, BS, Ting-Yu Huang, MS, Che-Wei Ou, MD, Der-Cherng Liang, MD, Lee-Yung Shih, MD

Blood (2016) 128 (22): 1969.

https://doi.org/10.1182/blood.V128.22.1969.1969

Published: 2016

Journal Articles

High Titers of Hepatitis B Surface Antibodies Indicating Low Risk of Hepatitis B Virus-Related Hepatitis in Lymphoma Patients Treated with Rituximab-Based Chemotherapy

Sung-Nan Pei, MD, Ming-Chung Wang, MD, Ming-Chung Ma, MD, Ching-Yuan Kuo, MD, Chien-Hung Chen, Po-Nan Wang, MD

Blood (2015) 126 (23): 3869.

https://doi.org/10.1182/blood.V126.23.3869.3869

Published: 2015

Journal Articles

Clinical Relevance of Molecular Markers in Taiwan Chinese Patients with Primary Myelofibrosis: Endogenous Erythroid Colony Growth Is the Most Important Predictor of Outcomes

Ming-Chung Kuo, MD, Tzung-Chih Tang, MD, Tung-Liang Lin, MD, Po-Nan Wang, MD, Po Dunn, MD, Jin-Hou Wu, MD, Hung Chang, MD, Tung-Huei Lin, MS, Chia-Hui Chang, BS, I-Jung Wu, MS, Lee-Yung Shih, MD

Blood (2015) 126 (23): 4083.

https://doi.org/10.1182/blood.V126.23.4083.4083

Published: 2015

Journal Articles

Clonal Evolution of Gene Mutations Involving DNA Methylation in the Progression of CMML to Secondary AML

Hsiao-Wen Kao, MD, Ming-Chung Kuo, MD, Po-Nan Wang, MD, Jin-Hou Wu, MD, Tung-Huei Lin, MS, Yu-Shu Shih, MS, Der-Cherng Liang, MD, Lee-Yung Shih, MD

Blood (2015) 126 (23): 4120.

https://doi.org/10.1182/blood.V126.23.4120.4120

Published: 2015

Journal Articles

Safety and Efficacy of Nilotinib (NIL) in Patients (Pts) with Chronic Phase (CP) or Accelerated Phase (AP) Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) with Resistance or Intolerance to Imatinib Mesylate (IM): Results from the Multicenter, Observational NOVEL Study in Taiwan

Ching-Yuan Kuo, MD, Po-Nan Wang, MD, Wen Li Hwang, MD, Cheng-Hwai Tzeng, MD, Li-Yuan Bai, MD, Jih-Luh Tang, MD PhD, Ming-Chih Chang, MD, Sheng-Fung Lin, MD, Tsai-Yun Chen, MD, Yeu-Chin Chen, MD, Tran-Der Tan, MD, Chih-Yi Hseih, MD, Chinjune Lin, MD, Miljkovic Darko, MD, Chang Cheng-Shyong, MD

Blood (2015) 126 (23): 1593.

https://doi.org/10.1182/blood.V126.23.1593.1593

Published: 2015

Journal Articles

Clonal Leukemic Evolution In Myelodysplastic Syndromes With ASXL1 and EZH2 mutations: A Comparative Analysis Of 58 Paired Samples

Hsuan-Jen Shih, MD, Lee-Yung Shih, MD, Hung Chang, MD, Ming-Chung Kuo, MD, Tung-Huei Lin, MS, Chen-Yu Lai, MS, Yu-Shu Shih, MS, Yu-Hui Huang, MS, Tung-Liang Lin, MD, Po-Nan Wang, MD, Jin-Hou Wu, MD

Blood (2013) 122 (21): 2786.

https://doi.org/10.1182/blood.V122.21.2786.2786

Published: 2013

Journal Articles

Clinical Utility of PRV-1 mRNA Expression Levels in Polycythemia Vera and Essential Thrombocythemia.

Hung Chang, MD, Yu-Shin Hung, MD, Chia-Hui Chang, Yu-Hui Huang, Tung-Liang Lin, MD, Tung-Huei Lin, Po Dunn, MD, Jin-Hou Wu, MD, Po-Nan Wang, MD, Ming-Chung Kuo, MD, Tzung-Chih Tang, MD, Lee-Yung Shih, MD

Blood (2012) 120 (21): 2846.

https://doi.org/10.1182/blood.V120.21.2846.2846

Published: 2012

Journal Articles

Clinical Implications of Reticulin Fibrosis of Bone Marrow in De Novo Acute Myeloid Leukemia.

Tzung-Chih Tang, MD, Hung Chang, MD, Chien-Feng Sun, MD, Lee-Yung Shih, MD, Po Dunn, MD, Po-Nan Wang, MD, Jin-Hou Wu, MD, Ming-Chung Kuo, MD, Tung-Liang Lin, MD, Yu-Shih Hung, MD, Hsiao-Wen Kao, MD

Blood (2012) 120 (21): 2585.

https://doi.org/10.1182/blood.V120.21.2585.2585

Published: 2012

Journal Articles

Different Patterns of AML1 Mutations between De Novo Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.

Lee-Yung Shih, Der-Cherng Liang, Chein-Fuang Huang, Ming-Chung Kuo, Tung-Liang Lin, Jen-Fen Fu, Yu-Shu Shih, Jin-Hou Wu, Po-Nan Wang, Po Dunn, Tzung-Chih Tang, Hung Chang

Blood (2007) 110 (11): 2442.

https://doi.org/10.1182/blood.V110.11.2442.2442

Published: 2007

Journal Articles

EEC Growth, JAK2 Mutation, PRV-1 Overexpression and X-Chromosome Inactivation Pattern: Predicting Values on Polycythemia Vera Evolution and Risk of Thrombosis in Idiopathic Thrombocytosis.

Lee-Yung Shih, MD, Ching-Tai Lee, BS, Tung-Liang Lin, MD, Chia-Hui Chang, BS, Chein-Fuang Huang, PhD, Po-Nan Wang, MD, Ming-Chung Kuo, MD, Po Dunn, MD, Jin-Hou Wu, MD, Hung Chang, MD, Yii-Jenq Lan, MD, Tzung-Chih Tang, MD

Blood (2006) 108 (11): 2692.

https://doi.org/10.1182/blood.V108.11.2692.2692

Published: 2006

Journal Articles

Mutations of Myeloid Transcription Factors AML1, CEBPα and PU.1 in Patients with De Novo Myelodysplastic Syndrome: An Analysis of Paired Bone Marrow Samples at Diagnosis and at AML Transformation.

Lee-Yung Shih, Der-Cherng Liang, Chein-Fuang Huang, Jin-Hou Wu, Po-Nan Wang, Ming-Chung Kuo, Po Dunn, Tzung-Chih Tang, Tung-Liang Lin, Hung Chang

Blood (2005) 106 (11): 3431.

https://doi.org/10.1182/blood.V106.11.3431.3431

Published: 2005

Journal Articles

High Frequency of AML1 Mutations in Patients with Chronic Myelomonocytic Leukemia.

Lee-Yung Shih, Chein-Fuang Huang, Der-Cherng Liang, Yu-Shu Shih, Jin-Hou Wu, Po Dunn, Po-Nan Wang, Ming-Chung Kuo

Blood (2005) 106 (11): 2855.

https://doi.org/10.1182/blood.V106.11.2855.2855

Published: 2005

Journal Articles

The Role of CEBP α Mutations in the Progression of Myeloid Leukemias.

Lee-Yung Shih, Chein-Fuang Huang, Der-Cherng Liang, Tung-Liang Lin, Jin-Hou Wu, Po-Nan Wang, Po Dunn, Ming-Chung Kuo, Chung-Chih Tang

Blood (2004) 104 (11): 3004.

https://doi.org/10.1182/blood.V104.11.3004.3004

Published: 2004

Journal Articles

Identification of Fusion Partners and Cooperating Mutations in De Novo AML with MLL Rearrangements.

Lee-Yung Shih, Der-Cherng Liang, Jen-Fen Fu, Jin-Hou Wu, Po-Nan Wang, Tung-Liang Lin, Chein-Fuang Huang, Po Dunn, Ming-Chung Kuo, Chung-Chih Tang, Tung-Huei Lin, Chang-Liang Lai

Blood (2004) 104 (11): 2010.

https://doi.org/10.1182/blood.V104.11.2010.2010

Published: 2004

NARROW

Impact of Allogeneic Hematopoietic Cell Transplantation in First Complete Remission in Addition to FLT3 Inhibition with Quizartinib in Acute Myeloid Leukemia with FLT3 -Internal Tandem Duplication: Results from the Quantum-First Trial

Quantum-First Trial: FLT3 -ITD-Specific MRD Clearance Is Associated with Improved Overall Survival

NOVEL-1 st : A Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

NOVEL-1 st : Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Differential Impact of Conditioning Intensity on Post-Transplant Outcome of FLT3 -Mutated and FLT3 Wild Type AML in First Remission, a Report from Taiwan Bone Marrow Transplant Registry (TBMTR)

Clonal Evolution of Gene Mutations in AML Transformation from Patients with De Novo Myelodysplastic Syndromes Carrying Spliceosome Mutations: An Analysis of 71 Paired Samples

High Titers of Hepatitis B Surface Antibodies Indicating Low Risk of Hepatitis B Virus-Related Hepatitis in Lymphoma Patients Treated with Rituximab-Based Chemotherapy

Clinical Relevance of Molecular Markers in Taiwan Chinese Patients with Primary Myelofibrosis: Endogenous Erythroid Colony Growth Is the Most Important Predictor of Outcomes

Clonal Evolution of Gene Mutations Involving DNA Methylation in the Progression of CMML to Secondary AML

Clonal Leukemic Evolution In Myelodysplastic Syndromes With ASXL1 and EZH2 mutations: A Comparative Analysis Of 58 Paired Samples

Clinical Utility of PRV-1 mRNA Expression Levels in Polycythemia Vera and Essential Thrombocythemia.

Clinical Implications of Reticulin Fibrosis of Bone Marrow in De Novo Acute Myeloid Leukemia.

Different Patterns of AML1 Mutations between De Novo Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.

EEC Growth, JAK2 Mutation, PRV-1 Overexpression and X-Chromosome Inactivation Pattern: Predicting Values on Polycythemia Vera Evolution and Risk of Thrombosis in Idiopathic Thrombocytosis.

Mutations of Myeloid Transcription Factors AML1, CEBPα and PU.1 in Patients with De Novo Myelodysplastic Syndrome: An Analysis of Paired Bone Marrow Samples at Diagnosis and at AML Transformation.

High Frequency of AML1 Mutations in Patients with Chronic Myelomonocytic Leukemia.

The Role of CEBP α Mutations in the Progression of Myeloid Leukemias.

Identification of Fusion Partners and Cooperating Mutations in De Novo AML with MLL Rearrangements.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only